Toft Group Completes Executive Search for Human Longevity, Inc. in San Diego, CA


Executive search firm Toft Group has placed Kenneth J. Bloom, M.D. as the new Head of Oncology and Immunotherapy at Human Longevity, Inc. (HLI), the genomics-based, technology-driven company in San Diego, CA. HLI recently announced its oncology program which includes the development of comprehensive whole germline and tumor genome analysis, as well as tumor and germline exome analysis products. Dr. Bloom has more than 30 years of clinical and business experience and has been an early adopter and big proponent of information technology to revolutionize pathology and other areas of medicine. He is also a prolific and renowned researcher and lecturer in pathology, cancer, telemedicine, and informatics.

"We are very pleased to have placed Dr. Bloom into this key role with Human Longevity guiding the company's oncology and immunotherapy strategy, and are certain that his efforts will yield better outcomes for cancer patients worldwide" said Robin Toft, President & CEO of Toft Group.

He comes to HLI most recently from GE Healthcare where he was since 2011 as Chief Medical Officer, In Vitro Diagnostics, Life Sciences. There he had oversight of Medical Affairs, Clinical Pathology Services, Pharma Pa thology Services, Bioinformatics and Research and Development. He was also President and CEO of Clarient Pathology Services, the professional group contracted to provide pathology services to Clarient Diagnostic Services and SeqWright. In these roles he led the overall development and execution of the medical and scientific strategy, aligning them with the overall GE mission and business strategy. Prior to Clarient, Dr. Bloom was with US Labs where he was Senior Medical Director since 2002.

In addition to Dr. Bloom’s extensive business experience, he has held a series of impressive academic medical posts including Clinical Professor of Pathology at University of Southern California, Keck School of Medicine; and Associate Professor of Pathology at Rush Medical College. During the last 15 years he has held more than 10 appointed positions at Rush Presbyterian-St. Luke’s Medical Center, one of the leading cancer research hospitals in the United States, including Director of Laboratory Operations, Director of Immunohistochemistry, and Director of Information Services for Rush Cancer Center.

Dr. Bloom received his M.D. from Rush Medical College and his B.A. from Grinnell College.

About Human Longevity, Inc.

Human Longevity, Inc. (HLI) is the genomics-based, technology-driven company creating the world’s largest and most comprehensive database of whole genome, phenotype and clinical data. HLI is developing and applying large scale computing and machine learning to make novel discoveries to revolutionize the practice of medicine. HLI’s business also includes the HLI Health Nucleus, a genomic powered clinical research center which uses whole genome sequence analysis, advanced clinical imaging and innovative machine learning, along with curated personal health information, to deliver the most complete picture of individual health.